How to Buy Praxis Precision Medicines Stock
Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance.
Praxis Precision Medicines stock last closed at $288.79, down 4.81% from the previous day, and has increased 684.33% in one year. It has overperformed other stocks in the Biotechnology industry by 7.23 percentage points. Praxis Precision Medicines stock is currently +981.61% from its 52-week low of $26.70, and -18.88% from its 52-week high of $356.00.
As of Mar 18, 2026, there are 27.85M PRAX shares outstanding. The market value of PRAX is $8.04B. In the last 24 hours, 409,000 PRAX shares were traded.
How to Buy Praxis Precision Medicines Stock
Not sure how to invest in Praxis Precision Medicines stock? Here's how.
- Figure out where to buy Praxis Precision Medicines stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Praxis Precision Medicines stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your method of payment and add your info.
- Research Praxis Precision Medicines stock: The Praxis Precision Medicines ticker symbol is PRAX. Is Praxis Precision Medicines stock a good investment? Should you buy shares of PRAX? How do PRAX's underlying business fundamentals look? Do top analysts think Praxis Precision Medicines is a good buy? Why has PRAX's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PRAX is a good stock to buy).
- Place your PRAX purchase: Decide if you will purchase PRAX shares at the current market price or use a limit order to buy PRAX stock at a specific price.
- Keep tabs on your PRAX investment: Create a watchlist to watch your investment in Praxis Precision Medicines shares.
Step 1: Figure out where to buy Praxis Precision Medicines stock
You need a brokerage account in order to access the NASDAQ market and buy PRAX shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to buy PRAX stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to start a new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've filled out your info on a good stock buying app, you can securely and quickly fund your account:
Check out the tutorial below if you need help transferring funds into your new brokerage account.
Step 4: Research Praxis Precision Medicines stock
After you have selected the best place to buy Praxis Precision Medicines stock, it's critical to evaluate their stock prior to investing, so you actually understand the risk as well as the upside.
Praxis Precision Medicines Numbers
PRAX Due Diligence Checks
WallStreetZen was created to help part-time investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on PRAX's stock page.
Is PRAX stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge PRAX's intrinsic value.
Using relative valuations measures:
- PRAX may be overvalued based on its P/B ratio of 9.16x, relative to Biotechnology industry P/B ratio of 4.65x
You can do more valuation research on PRAX's stock here.
PRAX Financials at a glance
Positive Financial Indicators:
- PRAX has cash burn of 249124000. It has enough cash and short-term investments to cover this for at least one year.
- PRAX has a low debt to equity ratio of 0.07.
- PRAX has $599.33M in cash and short term investments. This is sufficient to cover its annual cash burn of $249.12M.
- There are more short-term assets than short-term liabilities on the PRAX balance sheet.
- There are more short-term assets than long-term liabilities on the PRAX balance sheet.
Negative Financial Indicators:
- Total PRAX debt is higher than 5 years ago, relative to shareholder equity.
Is Praxis Precision Medicines stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 14 Wall Street analysts who give ratings on PRAX, the consensus analyst rating on Praxis Precision Medicines is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest PRAX Analyst Forecasts
Yatin Suneja, a top 3% analyst from Guggenheim maintains PRAX with a strong buy rating and raises their PRAX price target from $760.00 to $800.00, on Feb 10, 2026.
Guggenheim's Yatin Suneja raised their price target on Praxis Precision Medicines (NASDAQ: PRAX) by 5.3% from $760 to $800 on 2026/02/10. The analyst maintained their Strong Buy rating on the stock.
Praxis Precision Medicines will report its Q4 and FY 2025 earnings on 2026/02/19.
Suneja said Guggenheim's research and responses from key opinion leaders indicate that ulixacaltamide has the potential to penetrate the essential tremor (ET) market sufficiently to support a $15B-plus in that space and a $5B-$10B peak sales range for an effective branded oral.
The analyst noted that Praxis Precision Medicines is one of Guggenheim's 2026 Top Picks.
Ami Fadia, a top 1% analyst from Needham maintains PRAX with a buy rating and raises their PRAX price target from $460.00 to $510.00, on Feb 4, 2026.
Douglas Tsao, a top 2% analyst from HC Wainwright & Co. maintains PRAX with a buy rating and raises their PRAX price target from $340.00 to $1,245.00, on Jan 30, 2026.
Yasmeen Rahimi, a top 5% analyst from Piper Sandler maintains PRAX with a strong buy rating and raises their PRAX price target from $450.00 to $1,200.00, on Jan 28, 2026.
Kambiz Yazdi, a top 24% analyst from BTIG maintains PRAX with a strong buy rating and raises their PRAX price target from $507.00 to $843.00, on Dec 29, 2025.
You can dive deeper into what analysts are projecting on the Praxis Precision Medicines stock forecast page.
PRAX Trading Indicators
PRAX Growth Metrics
Last year, PRAX revenue was $0.00. Over the last 2 year, PRAX's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 28.92%.
Learn more about PRAX's earnings and revenue performance here.
Are PRAX insiders buying or selling the stock?
Over the past 12 months, insiders at PRAX have sold more shares than they have bought.
Timothy Edwin Kelly, Chief Financial Officer of PRAX, was the latest PRAX insider to sell. They sold $260,022.82 worth of PRAX shares on Jan 12, 2026.
Learn more about who owns PRAX shares here.
Can I rely on PRAX as an income stream?
No, Praxis Precision Medicines doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your PRAX purchase
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, use a limit order.
Hit the Open button and your broker will execute the order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your PRAX investment
Now that you own some PRAX stock, you'll want to stay up-to-date on your new investment.
Make a watchlist to track your PRAX stock.
PRAX Feed
How to Buy Stock in Praxis Precision Medicines
To reiterate, here are the 6 steps to buy Praxis Precision Medicines stock:
- Figure out where to buy Praxis Precision Medicines stock
- Create a brokerage account
- Deposit funds into your investment account
- Research Praxis Precision Medicines stock
- Place your PRAX purchase
- Keep tabs on your PRAX investment
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Praxis Precision Medicines, click below.
More "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.